Entrada Therapeutics to Present at Upcoming Investor Conferences

Core Insights - Entrada Therapeutics, Inc. will participate in two upcoming investor conferences, highlighting its engagement with the investment community [1][2][3] Group 1: Upcoming Events - The CEO, Dipal Doshi, will present at the Jefferies Global Healthcare Conference in London on November 18, 2025, at 5:00 p.m. GMT [2] - Dipal Doshi will also participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on December 3, 2025, at 12:55 p.m. ET in Miami, FL [3] - Live webcasts of these events will be available on the Investor Relations section of the company's website, with replays accessible for 90 days post-event [3] Group 2: Company Overview - Entrada Therapeutics is a clinical-stage biopharmaceutical company focused on developing a new class of medicines targeting intracellular mechanisms previously deemed inaccessible [4] - The company's proprietary Endosomal Escape Vehicle (EEV™) therapeutics aim to enhance the intracellular delivery of various therapeutics, improving the therapeutic index [4] - Entrada is advancing a development portfolio that includes RNA- and protein-based programs for treating neuromuscular and ocular diseases, with lead programs targeting Duchenne muscular dystrophy [4]